Brookfield Corp’s Tandem Diabetes Care TNDM Stock Holding History

Brookfield Corp’s Portfolio TNDM Stock Details TNDM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-56,816	Closed	-$2.31M	–	744
2023 Q1	$2.31M	Buy	56,816 +22,595	+66%	+$935K	0.01%	407
2022 Q4	$1.54M	Sell	34,221 -19,939	-37%	-$903K	0.01%	449
2022 Q3	$2.59M	Buy	+54,160	New	+$2.97M	0.01%	400
2022 Q2	–	Sell	-9,697	Closed	-$1.13M	–	747
2022 Q1	$1.13M	Buy	9,697 +3,972	+69%	+$464K	﹤0.01%	483
2021 Q4	$862K	Buy	+5,725	New	+$773K	﹤0.01%	480

Other funds holding TNDM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Eminence Capital New York $4.36B AUM 3.1% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $3.89B AUM 16.15% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return

Brookfield Corp's TNDM Position: Q2 2023 in Review

Brookfield Corp sold out of Tandem Diabetes Care (TNDM) in Q2 2023, closing a stake of 56,816 shares — an estimated $2.31M sold.

Brookfield Corp first reported a position in TNDM in Q4 2021 and held it in 5 quarters. The position peaked at $2.59M in Q3 2022. 247 funds tracked by Wall St. Rank hold TNDM as of Q2 2023.

Brookfield Corp reported no remaining Tandem Diabetes Care position as of Q2 2023 after selling out during the quarter.
Brookfield Corp sold 56,816 Tandem Diabetes Care shares in Q2 2023, an estimated $2.31M.
Brookfield Corp first reported a position in Tandem Diabetes Care in Q4 2021 and held it in 5 quarters.
Brookfield Corp's Tandem Diabetes Care position peaked at $2.59M in Q3 2022.
247 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q2 2023.

Based on Brookfield Corp's 13F filing for Q2 2023, filed 14 Aug 2023.